Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1994 Mar;85(3):306–314. doi: 10.1111/j.1349-7006.1994.tb02098.x

Opposing Effects of Indomethacin and Nordihydroguaiaretic Acid on Macrophage Function and Tumor Growth

Michihiro Suzuki 1,✉, Jey Li 1, Toshio Asakura 2, Kazuhiko Arai 1
PMCID: PMC5919455  PMID: 8188530

Abstract

The effects of indomethacin (INDO) and nordihydroguaiaretic acid (NDGA) were compared on macrophage function and tumor growth. Intraperitoneal injections (5 mg/kg/day, 6, 8 or 9 days) of INDO in C57BL/6 mice stimulated the cytotoxicity of peritoneal macrophages and inhibited growth of subcutaneous B16 melanoma, whereas NDGA injections suppressed macrophage cytotoxicity, increased macrophage prostaglandin‐E2 (PGE2) release, and enhanced the tumor growth. Further, pretreatment of macrophages in vitro with the INDO group serum increased cytostasis against B16 tumor cells, while the use of NDGA group serum reduced it. Incubation of tumor‐bearer's macrophages in vitro with INDO (10‐6M and 10‐7M) or 10‐6M NDGA for 4 h reduced PGE2 release, but 10 ‐7M NDGA markedly enhanced the PGE2 release. Our data indicate that INDO and NDGA are able to modulate the macrophage function directly, and produce opposing effects on macrophage function and tumor growth. Inhibitory actions of INDO and NDGA on the cyclooxygenase or lipoxygenase pathway of arachidonic acid metabolism appear to contribute to their effects.

Keywords: Opposing effects, Indomethacin, Nordihydroguaiaretic acid, Tumor growth, Macrophage function

Full Text

The Full Text of this article is available as a PDF (492.8 KB).

REFERENCES

  • 1. ) Fulton , A. M.In vivo effect of indomethacin on the growth of murine mammary tumors . Cancer Res. , 44 , 2416 – 2420 ( 1984. ). [PubMed] [Google Scholar]
  • 2. ) Young , M. R. and Knies , S.Prostaglandin E production by Lewis lung carcinoma: mechanism for tumor establishment in vivo . J. Natl. Cancer Inst. , 72 , 919 – 922 ( 1984. ). [PubMed] [Google Scholar]
  • 3. ) Narisawa , T. , Sato , M. , Tani , M. , Kudo , T. , Takahashi , T. and Goto , A.Inhibition of development of methylnitrosourea‐induced rat colon tumors by indomethacin treatment . Cancer Res. , 41 , 1954 – 1957 ( 1981. ). [PubMed] [Google Scholar]
  • 4. ) Valdez , J. C. and Perdigon , G.Piroxicam, indomethacin and aspirin action on murine fibrosarcoma. Effects on tumor‐associated and peritoneal macrophages . Clin. Exp. Immunol. , 86 , 315 – 321 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. ) Pallard , M. and Luckert , P. H.Effect of indomethacin on intestinal tumor induced in rats by the acetate derivative of dimethylnitrosamine . Science , 214 , 558 – 559 ( 1981. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Furuta , Y. , Hall , E. R. , Sanduja , S. , Barkley , T. , Jr. and Milas , L.Prostaglandin production by murine tumors as a predictor for therapeutic response to indomethacin . Cancer Res. , 48 , 3002 – 3007 ( 1988. ). [PubMed] [Google Scholar]
  • 7. ) Klein , W. A. , Miller , H. H. , Anderson , M. and Decosse , J. J.The use of indomethacin, sulindac, and tamoxifen for the treatment of desmoid tumors associated with familial polyposis . Cancer , 60 , 2863 – 2868 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Ikeda , T. , Tozuka , S. , Hasumura , Y. and Takeuchi , J.Prostaglandin E‐producing hepatocellular carcinoma with hypercalcemia . Cancer , 61 , 1813 – 1814 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Rosemberg , L. , Palmer , J. R. , Zauber , A. G. , Warshauer , M. E. , Stolley , P. D. and Shapiro , S.A hypothesis: non‐steroidal anti‐inflammatory drugs reduce the incidence of large‐bowel cancer . J. Natl. Cancer Inst , 83 , 355 – 358 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 10. ) Young , M. R. and Newby , M.Enhancement of Lewis lung carcinoma cell migration by prostaglandin E2 produced by macrophages . Cancer Res. , 46 , 160 – 164 ( 1986. ). [PubMed] [Google Scholar]
  • 11. ) Tilden , A. B. , Dougherty , P. A. and Balch , C. M.Differential effects of indomethacin and PGE2 on the depressed responses of cancer patients . In “ Prostaglandins and Cancer ,” ed. Powles T. J. , Bockman R. S. , Honn K. V. and Ramwell K. V. , pp. 651 – 655 ( 1982. ). Alan R. Liss. Inc. , New York , NY . [Google Scholar]
  • 12. ) Fidler , I. J.Macrophages and metastasis, a biological approach to cancer therapy: presidential address . Cancer Res. , 45 , 4714 – 4726 ( 1985. ). [PubMed] [Google Scholar]
  • 13. ) Dempsey , R. A. , Dinarello , C. A. , Mier , J. W. , Rosenwasser , L. J. , Allegretta , M. , Brown , T. E. and Parkinson , D. R.The differential effects of human leukocytic pyrogen/lymphocyte‐activating factor, T cell growth factor, and interferon on human natural killer activity . J Immunol. , 129 , 2504 – 2510 ( 1982. ). [PubMed] [Google Scholar]
  • 14. ) Nathan , C. F.Secretary products of macrophages . J. Clin. Invest. , 79 , 319 – 326 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. ) Arai , K. , Asakura , T. and Nemir , P. , Jr.Effect of local tumor removal and retained oncolysate on lung metastasis . J. Surg. Res. , 53 , 30 – 38 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 16. ) Martin , F. , Caignard , A. , Olsson , O. , Jeannin , J. F. and Leclerc , A.Tumoricidal effect of macrophages exposed to adriamycin in vivo or in vitro . Cancer Res. , 42 , 3851 – 3857 ( 1982. ). [PubMed] [Google Scholar]
  • 17. ) Snedecor , G. W. and Cochran , W. G. “ Statistical Methods ,” 7th Ed. ( 1980. ). The Iowa State Univ. , Ames , IA . [Google Scholar]
  • 18. ) Taffet , S. M. and Russell , S. W.Macrophage‐mediated tumor cell killing: regulation of expression of cytolytic activity by prostaglandin E . J. Immunol. , 126 , 424 – 427 ( 1981. ). [PubMed] [Google Scholar]
  • 19. ) Elliott , G. R. , Tak , C. , Pellens , C. , Ben‐Efraim , S. and Bonta , I. L.Indomethacin stimulation of macrophage cytostasis against MOPC‐315 tumor cells is inhibited by both prostaglandin E2 and nordihydroguaiaretic acid, a lipoxygenase inhibitor . Cancer Immunol. Immunother. , 27 , 133 – 136 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. ) Webb , D. R. and Nowowiejski , I.Control of suppressor cell activation via endogenous prostaglandin synthesis: the role of T cell and macrophages . Cell Immunol. , 63 , 321 – 328 ( 1981. ). [DOI] [PubMed] [Google Scholar]
  • 21. ) Bennett , J. A. , Marsh , J. C. and Mitchell , M. S.Suppressor macrophages: their induction, characterization and regulation . Prog. Cancer Res. Therap. , 19 , 9 – 26 ( 1981. ). [Google Scholar]
  • 22. ) Pope , B. L.The effect of indomethacin on the activation and effector function of suppressor cells from tumor‐bearing mice . Cancer Immunol. Immunother. , 19 , 101 – 108 ( 1985. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. ) Bhattacherjee , P. , Boughton‐Smith , N. K. , Follenfant , R. L. , Garland , L. G. , Higges , G. A. , Hodson , H. F. , Islip , P. J. , Jackson , W. P. , Moncada , S. , Payne , A. N. , Randall , R. W. , Reynolds , C. H. , Salmon , J. A. , Tateson , J. E. and Whittle , B. J. R.The effects of a novel series of selective inhibitors of arachidonate 5‐lipoxygenase on anaphylactic and inflammatory responses . Ann. N. Y. Acad. Sci. , 524 , 307 – 320 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 24. ) Schewe , T. , Kuhn , H. and Rapoport , S. M.Lipoxygenases: measurement, characterization and properties . In “ Prostaglandins and Related Substances ,” ed. Benedetto C. , McDonald‐Gibson R. G. , Nigam S. and Slater T. F. , pp. 229 – 242 ( 1988. ). IRL Press; , Oxford . [Google Scholar]
  • 25. ) Ophir , R. , Ben‐Efraim , S. and Bonta , I. L.Leukotriene D4 and indomethacin enhance additively the macrophage cytostatic activity in vitro towards MOPC‐315 tumor cells . Int. J. Tissue React. , 9 , 189 – 194 ( 1987. ). [PubMed] [Google Scholar]
  • 26. ) Braun , D. P. , Ahn , M. , Harris , J. E. , Chu , E. , Casey , L. , Wilbanks , G. and Siziopikou , K. P.Sensitivity of tumoricidal function in macrophages from different anatomical sites of cancer patient to modulation of arachidonic acid metabolism . Cancer Res. , 53 , 3362 – 3368 ( 1993. ). [PubMed] [Google Scholar]
  • 27. ) Kunkel , S. L. , Chensue , S. W. and Phan , S. H.Prostaglandins as endogenous mediator of interleukin 1 production . J. Immunol. , 136 , 186 – 192 ( 1986. ). [PubMed] [Google Scholar]
  • 28. ) Rola‐Pleszczynski , M. and Lemaire , I.Leukotrienes augment interleukin 1 production by human monocytes . J. Immunol. , 135 , 3958 – 3961 ( 1985. ). [PubMed] [Google Scholar]
  • 29. ) Parnham , M. J. , Bittner , C. and Winkelmann , J.Chemiluminescence from mouse resident macrophages: characterization and modulation by arachidonate metabolites . Immunopharmacology , 5 , 277 – 291 ( 1983. ). [DOI] [PubMed] [Google Scholar]
  • 30. ) Schenkelaars , E. and Bonta , I. L.Cyclooxygenase inhibitors promote the leukotriene C4 induced release of betaglucuronidase from rat peritoneal macrophages: prostaglandin E2 suppresses . Int. J. Immunopharmacol. , 8 , 305 – 311 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 31. ) Thun , M. J. , Namboodiri , M. M. and Heath , C. W. , Jr.Aspirin use and reduced risk of fetal colon cancer . N. Engl. J. Med. , 325 , 1593 – 1596 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 32. ) Waddell , W. R. , Ganser , G. F. , Cerise , E. J. and Loughry , R. W.Sulindac for polyposis of the colon . Am. J. Surg. , 157 , 175 – 179 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 33. ) Labayle , D. , Fischer , D. , Vielh , P. , Drouhin , F. , Pariente , A. , Bories , C. , Duhamel , O. , Trousset , M. and Attali , P.Sulindac causes regression of rectal polyps in familial adenomatous polyposis . Gastroenterology , 101 , 635 – 639 ( 1991. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES